Changes in Beneficial Ownership · 4
Compugen Ltd.
CGENNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-04-24
- Issuer
- COMPUGEN LTD
- Issuer CIK
- 0001119774
- Trading symbol
- CGEN
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Levine Zurit
- Reporting owner CIK
- 0001972527
- Relationship
- Officer
- Officer title
- SVP, Business Development
- Address
- C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL, L3, 5885849
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 2026-04-24 | M · Form 4[F1] | 2,000 | A | 1.15 | 31,375 | D |
| Ordinary Shares | 2026-04-24 | S · Form 4[F1] | 2,000 | D | 3.20 | 29,375 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy) | 1.15 | 2026-04-24 | M · Form 4[F1] | 2,000 | D | 0 | [F2] | 2033-08-03 | Ordinary Shares | 2,000 | 52,000 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.↩ 1↩ 2↩ 3
- F2
- This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.↩ 1
Signature 1
- Signed
- /s/ Zurit Levine
- Date
- 2026-04-27